"Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug (molnupiravir) made by US pharma group Merck, raising questions about the costly procurement of antivirals during the peak of the pandemic."
https://www.ft.com/content/c4b3f696-327f-4a3a-8594-885599ae6f8d
@cyrilpedia I'm a supporter of FDA generally ... its role is vital.
Given its known mutagenic mechanism of action and the availability of a safer and efficacious alternative (Paxlovid)... it's a mystery to me why this drug was authorized by #FDA .
@mzchem_Murphy @lymphomation Thanks for the heads, I love that podcast - it was a treat to speak with Racaniello for the #EMBOPodcast
https://www.embo.org/podcasts/lessons-of-epidemics-past-and-present/